Cerus to Present at Cantor Fitzgerald’s Annual Healthcare Conference on September 27, 2017
September 20 2017 - 08:30AM
Business Wire
Cerus Corporation (NASDAQ:CERS) announced today that William
‘Obi’ Greenman, Cerus’ president and chief executive officer, is
scheduled to present a corporate update at the Cantor Fitzgerald
Healthcare Conference at 10:20 AM ET on Wednesday, September 27,
2017.
A live webcast of the presentation will be available from the
Investor Relations page of the Cerus web site at
http://www.cerus.com/ir. A replay will be available for
approximately two weeks following the completion of the event.
ABOUT CERUS
Cerus Corporation is a biomedical products company focused in
the field of blood transfusion safety. The INTERCEPT Blood System
is designed to reduce the risk of transfusion-transmitted
infections by inactivating a broad range of pathogens such as
viruses, bacteria and parasites that may be present in donated
blood. The nucleic acid targeting mechanism of action of the
INTERCEPT treatment is designed to inactivate established
transfusion threats, such as hepatitis B and C, HIV, West Nile
virus and bacteria, as well as emerging pathogens such as
chikungunya, malaria and dengue. Cerus currently markets and sells
the INTERCEPT Blood System for both platelets and plasma in the
United States, Europe, the Commonwealth of Independent States, the
Middle East and selected countries in other regions around the
world. The INTERCEPT Red Blood Cell system is in clinical
development. See http://www.cerus.com for information about
Cerus.
INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus
Corporation.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170920005412/en/
Cerus CorporationTim Lee, 925-288-6137Investor Relations
Director
Cerus (NASDAQ:CERS)
Historical Stock Chart
From Feb 2024 to Mar 2024
Cerus (NASDAQ:CERS)
Historical Stock Chart
From Mar 2023 to Mar 2024